{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:29:57Z","timestamp":1792661397478,"version":"4.5.0"},"reference-count":23,"publisher":"American College of Physicians","issue":"5","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2016,3,1]]},"DOI":"10.7326\/m15-0880","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T21:32:48Z","timestamp":1454362368000},"page":"313-322","source":"Crossref","is-referenced-by-count":82,"title":["Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention"],"prefix":"10.7326","volume":"164","author":[{"given":"Lindsey R.","family":"Baden","sequence":"first","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Karita","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaudensia","family":"Mutua","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Gray","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Page-Shipp","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Walsh","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Nyombayire","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omu","family":"Anzala","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surita","family":"Roux","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laher","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Innes","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda Z.","family":"Cohen","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Peter","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Frahm","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Swann","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Grunenberg","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grazia-Pau","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Weijtens","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Sadoff","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Len","family":"Dally","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lombardo","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Gilmour","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Cox","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Dolin","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fast","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagna S.","family":"Laufer","sequence":"additional","affiliation":[{"name":"From Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts; Projet San Francisco, Kigali, Rwanda; Kenya AIDS Vaccine Initiative and University of Nairobi, Nairobi, Kenya; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; Perinatal HIV Research Unit, Soweto, South Africa; Aurum Institute for Health Research, Klerksdorp, South Africa;"},{"name":"Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Fred Hutchinson Cancer Research Center and HIV Vaccine Trials Network, Seattle, Washington; International AIDS Vaccine Initiative Human Immunology Laboratory, London, United Kingdom; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; Janssen Pharmaceuticals Infectious Diseases and Vaccines (formerly Crucell Holland), Leiden, the Netherlands;"},{"name":"EMMES Corporation, Rockville, Maryland; International AIDS Vaccine Initiative, New York, New York; and Global BioSolutions, Craigieburn, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the B003-IPCAVD004-HVTN091 Study Group*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4285","reference":[{"key":"r1-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61591-3"},{"key":"r2-M150880","doi-asserted-by":"publisher","DOI":"10.1086\/428404"},{"key":"r3-M150880","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310566"},{"key":"r4-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61592-5"},{"key":"r5-M150880","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908492"},{"key":"r6-M150880","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir615"},{"key":"r7-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.03.083"},{"key":"r8-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.02.072"},{"key":"r9-M150880","author":"Nicholson O","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"r10-M150880","doi-asserted-by":"publisher","DOI":"10.1086\/509258"},{"key":"r11-M150880","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00144-09"},{"key":"r12-M150880","doi-asserted-by":"publisher","DOI":"10.1086\/587993"},{"key":"r13-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.025"},{"key":"r14-M150880","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.145"},{"key":"r15-M150880","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis670"},{"key":"r16-M150880","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis671"},{"key":"r17-M150880","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041936"},{"key":"r18-M150880","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02407-10"},{"key":"r19-M150880","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00311-10"},{"key":"r20-M150880","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078679"},{"key":"r21-M150880","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00004-07"},{"key":"r22-M150880","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26038"},{"key":"r23-M150880","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000067"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/M15-0880","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/M15-0880","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/annals.org\/article.aspx?doi=10.7326\/M15-0880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T08:15:47Z","timestamp":1739088947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/M15-0880"}},"subtitle":["A Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3,1]]}},"alternative-id":["10.7326\/M15-0880"],"URL":"https:\/\/doi.org\/10.7326\/m15-0880","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}